Late onset Epstein-Barr virus-associated lymphoproliferative disease after allogeneic bone marrow transplant presenting as breast masses. 1998

S H Abhyankar, and K Y Chiang, and J P McGuirk, and A R Pati, and K T Godder, and J A Welsh, and R L Waldron, and J L McElveen, and P J Henslee-Downey
Department of Medicine, University of South Carolina and Richland Memorial Hospital, Columbia 29203, USA.

We report a patient who developed breast masses 17 months after a T cell-depleted partially mismatched related donor (PMRD) bone marrow transplant (BMT) for chronic myeloid leukemia. The patient had severe chronic graft-versus-host disease (GVHD) and the masses were due to Epstein-Barr virus (EBV) lymphoproliferative disease (LPD). The patient expired from fungal pneumonia after chemotherapy for the EBV-LPD.

UI MeSH Term Description Entries
D008172 Lung Diseases, Fungal Pulmonary diseases caused by fungal infections, usually through hematogenous spread. Fungal Lung Diseases,Pulmonary Fungal Infections,Pulmonary Fungal Diseases,Fungal Disease, Pulmonary,Fungal Diseases, Pulmonary,Fungal Infection, Pulmonary,Fungal Infections, Pulmonary,Fungal Lung Disease,Lung Disease, Fungal,Pulmonary Fungal Disease,Pulmonary Fungal Infection
D001940 Breast In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES. Breasts
D002051 Burkitt Lymphoma A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative. African Lymphoma,Burkitt Cell Leukemia,Burkitt Tumor,Lymphoma, Burkitt,Burkitt Leukemia,Burkitt's Leukemia,Burkitt's Lymphoma,Burkitt's Tumor,Leukemia, Lymphoblastic, Burkitt-Type,Leukemia, Lymphocytic, L3,Lymphocytic Leukemia, L3,Burkitts Leukemia,Burkitts Lymphoma,Burkitts Tumor,L3 Lymphocytic Leukemia,L3 Lymphocytic Leukemias,Leukemia, Burkitt,Leukemia, Burkitt Cell,Leukemia, Burkitt's,Leukemia, L3 Lymphocytic,Lymphoma, African,Lymphoma, Burkitt's,Tumor, Burkitt,Tumor, Burkitt's
D004854 Herpesvirus 4, Human The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies. Burkitt Herpesvirus,Burkitt Lymphoma Virus,E-B Virus,EBV,Epstein-Barr Virus,Human Herpesvirus 4,Infectious Mononucleosis Virus,Burkitt's Lymphoma Virus,HHV-4,Herpesvirus 4 (gamma), Human,Burkitts Lymphoma Virus,E B Virus,E-B Viruses,Epstein Barr Virus,Herpesvirus, Burkitt,Infectious Mononucleosis Viruses,Lymphoma Virus, Burkitt,Mononucleosis Virus, Infectious,Mononucleosis Viruses, Infectious
D005260 Female Females
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001228 Aspergillosis Infections with fungi of the genus ASPERGILLUS. Aspergillus Infection,Aspergilloses,Aspergillus Infections,Infection, Aspergillus,Infections, Aspergillus

Related Publications

S H Abhyankar, and K Y Chiang, and J P McGuirk, and A R Pati, and K T Godder, and J A Welsh, and R L Waldron, and J L McElveen, and P J Henslee-Downey
May 2000, Pediatric transplantation,
S H Abhyankar, and K Y Chiang, and J P McGuirk, and A R Pati, and K T Godder, and J A Welsh, and R L Waldron, and J L McElveen, and P J Henslee-Downey
January 2001, Journal of immunotherapy (Hagerstown, Md. : 1997),
S H Abhyankar, and K Y Chiang, and J P McGuirk, and A R Pati, and K T Godder, and J A Welsh, and R L Waldron, and J L McElveen, and P J Henslee-Downey
December 2006, International journal of hematology,
S H Abhyankar, and K Y Chiang, and J P McGuirk, and A R Pati, and K T Godder, and J A Welsh, and R L Waldron, and J L McElveen, and P J Henslee-Downey
November 1993, Transplantation,
S H Abhyankar, and K Y Chiang, and J P McGuirk, and A R Pati, and K T Godder, and J A Welsh, and R L Waldron, and J L McElveen, and P J Henslee-Downey
January 2021, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
S H Abhyankar, and K Y Chiang, and J P McGuirk, and A R Pati, and K T Godder, and J A Welsh, and R L Waldron, and J L McElveen, and P J Henslee-Downey
April 1994, The New England journal of medicine,
S H Abhyankar, and K Y Chiang, and J P McGuirk, and A R Pati, and K T Godder, and J A Welsh, and R L Waldron, and J L McElveen, and P J Henslee-Downey
May 2008, The Australasian journal of dermatology,
S H Abhyankar, and K Y Chiang, and J P McGuirk, and A R Pati, and K T Godder, and J A Welsh, and R L Waldron, and J L McElveen, and P J Henslee-Downey
August 2023, EJHaem,
S H Abhyankar, and K Y Chiang, and J P McGuirk, and A R Pati, and K T Godder, and J A Welsh, and R L Waldron, and J L McElveen, and P J Henslee-Downey
November 2014, Current opinion in hematology,
S H Abhyankar, and K Y Chiang, and J P McGuirk, and A R Pati, and K T Godder, and J A Welsh, and R L Waldron, and J L McElveen, and P J Henslee-Downey
October 1997, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses,
Copied contents to your clipboard!